Morning Briefing
Summaries of health policy coverage from major news organizations
Johnson & Johnson Sets A Record With $8.9 Billion Talc Settlement Offer
Johnson & Johnson's talc聽saga may聽finally be nearing an end. The drugmaker on Tuesday said it鈥檚 offering $8.9 billion over 25 years to resolve all lawsuits claiming that the company鈥檚 talc-containing baby powders caused cancer. The deal proposal comes after years of litigation and a high profile, $2 billion verdict which J&J unsuccessfully appealed all the way to the Supreme Court. This settlement聽proposal could end what would otherwise take decades of legal proceedings, J&J鈥檚 vice president of litigation, Erik Haas, said in a statement Tuesday. It would also聽compensate the claimants 鈥渋n a timely manner鈥� while allowing J&J to focus on its business, Haas added. (Liu and Sagonowsky, 4/4)
Attorney Mikal Watts of Watts Guerra, a law firm that has been in negotiations with J&J since January, said the new settlement would be the 鈥渓argest products liability settlement ever realized after a bankruptcy filing.鈥� (Bhattacharya, 4/5)
Johnson & Johnson said that the settlement and bankruptcy filing did not mean it 鈥渉as changed its longstanding position that its talcum powder products are safe.鈥� The company has long denied claims that its products containing talc 鈥� a mineral used to absorb moisture 鈥� cause cancer. The company said the settlement is intended to 鈥渞esolve all the current and future talc claims.鈥� But for the settlement to come to fruition, the bankruptcy filing must be approved by the U.S. Bankruptcy Court for the District of New Jersey. (Pietsch, 4/5)
The J&J subsidiary, LTL Management, filed for bankruptcy protection late Tuesday for a second time with the intent to present a reorganization plan containing the proposed settlement to a judge as soon as May 14, the subsidiary said in a court filing. J&J said in a statement that about 60,000 talc claimants had agreed to the proposal. (Knauth andSpector, 4/4)